ReP USP - Resultado da busca

Artigo de periodico
Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum (2019)
Vasconcelos, Stanley Nunes Siqueira ; Meissner, Kamila Anna ; Ferraz, Witor R.; Trossini, Gustavo Henrique Goulart ; Wrenger, Carsten ; Stefani, Hélio Alexandre
Source: Future Medicinal Chemistry. Unidades: FCF, ICB
Subjects: MALÁRIA, PLASMODIUM FALCIPARUM, PROTOZOA, ANTIMALÁRICOS, ANIMAIS PARASITOS, VIRULÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASCONCELOS, Stanley Nunes Siqueira et al. Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum. Future Medicinal Chemistry, v. 11, n. 6, p. 525-538, 2019Tradução . . Disponível em: https://doi.org/10.4155/fmc-2018-0246. Acesso em: 18 nov. 2024.
APA
Vasconcelos, S. N. S., Meissner, K. A., Ferraz, W. R., Trossini, G. H. G., Wrenger, C., & Stefani, H. A. (2019). Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum. Future Medicinal Chemistry, 11( 6), 525-538. doi:10.4155/fmc-2018-0246
NLM
Vasconcelos SNS, Meissner KA, Ferraz WR, Trossini GHG, Wrenger C, Stefani HA. Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum [Internet]. Future Medicinal Chemistry. 2019 ; 11( 6): 525-538.[citado 2024 nov. 18 ] Available from: https://doi.org/10.4155/fmc-2018-0246
Vancouver
Vasconcelos SNS, Meissner KA, Ferraz WR, Trossini GHG, Wrenger C, Stefani HA. Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum [Internet]. Future Medicinal Chemistry. 2019 ; 11( 6): 525-538.[citado 2024 nov. 18 ] Available from: https://doi.org/10.4155/fmc-2018-0246
Artigo de periodico
Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening (2018)
Meissner, Kamila Anna ; Kronenberger, Thales ; Maltarollo, Vinícius Gonçalves ; Trossini, Gustavo Henrique Goulart ; Wrenger, Carsten
Source: Chemical Biology and Drug Design. Unidades: FCF, ICB
Subjects: PLASMODIUM FALCIPARUM, PARASITOLOGIA, MALÁRIA, QUIMIOTERAPIA, ENZIMAS PROTEOLITICAS, ATIVAÇÃO ENZIMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEISSNER, Kamila Anna et al. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, v. 2018 p. 1-13, 2018Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13416. Acesso em: 18 nov. 2024.
APA
Meissner, K. A., Kronenberger, T., Maltarollo, V. G., Trossini, G. H. G., & Wrenger, C. (2018). Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, 2018 p. 1-13. doi:10.1111/cbdd.13416
NLM
Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/cbdd.13416
Vancouver
Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/cbdd.13416
Artigo de periodico
Advances and challenges in drug design of PPARδ ligands (2018)
Maltarollo, Vinícius Gonçalves ; Kronenberger, Thales ; Windshuegel, Bjoern ; Wrenger, Carsten ; Trossini, Gustavo Henrique Goulart ; Honório, Káthia Maria
Source: Current Drug Targets. Unidades: ICB, FCF, EACH
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, SÍNDROME X METABÓLICA, ÁCIDOS GRAXOS, DOENÇAS METABÓLICAS, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinícius Gonçalves et al. Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, v. 19, n. 2, p. 144-154, 2018Tradução . . Disponível em: https://doi.org/10.2174/1389450118666170414113159. Acesso em: 18 nov. 2024.
APA
Maltarollo, V. G., Kronenberger, T., Windshuegel, B., Wrenger, C., Trossini, G. H. G., & Honório, K. M. (2018). Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, 19( 2), 144-154. doi:10.2174/1389450118666170414113159
NLM
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Vancouver
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Artigo de periodico
Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses (2017)
Kronenberger, Thales; Asse Junior, Leonardo Rander; Wrenger, Carsten ; Trossini, Gustavo Henrique Goulart ; Honorio, Kathia Maria; Maltarollo, Vinícius Gonçalves
Source: Future Medicinal Chemistry. Unidades: EACH, ICB, FCF
Subjects: STAPHYLOCOCCUS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRONENBERGER, Thales et al. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses. Future Medicinal Chemistry, v. 9, n. 2, p. 135-151, 2017Tradução . . Disponível em: https://doi.org/10.4155/fmc-2016-0179. Acesso em: 18 nov. 2024.
APA
Kronenberger, T., Asse Junior, L. R., Wrenger, C., Trossini, G. H. G., Honorio, K. M., & Maltarollo, V. G. (2017). Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses. Future Medicinal Chemistry, 9( 2), 135-151. doi:10.4155/fmc-2016-0179
NLM
Kronenberger T, Asse Junior LR, Wrenger C, Trossini GHG, Honorio KM, Maltarollo VG. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses [Internet]. Future Medicinal Chemistry. 2017 ; 9( 2): 135-151.[citado 2024 nov. 18 ] Available from: https://doi.org/10.4155/fmc-2016-0179
Vancouver
Kronenberger T, Asse Junior LR, Wrenger C, Trossini GHG, Honorio KM, Maltarollo VG. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses [Internet]. Future Medicinal Chemistry. 2017 ; 9( 2): 135-151.[citado 2024 nov. 18 ] Available from: https://doi.org/10.4155/fmc-2016-0179

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em